Hamps Bio Limited (BOM:544312)

Hamps Bio Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1.7	0.96	0.58	0.49	0.51
Cash & Short-Term Investments	1.7	0.96	0.58	0.49	0.51
Cash Growth	77.12%	63.87%	19.67%	-4.50%	-66.89%
Accounts Receivable	15.85	11.92	9.89	7.6	6.91
Other Receivables	-	4.97	0.04	0.06	-
Receivables	15.85	16.89	9.94	7.66	6.91
Inventory	25.82	23.8	12.28	3.67	5.69
Prepaid Expenses	-	0.04	-	0.03	-
Other Current Assets	9.6	0.71	1.57	0.48	0.22
Total Current Assets	52.97	42.41	24.37	12.32	13.32
Property, Plant & Equipment	90.44	57.58	25.24	26.06	21.54
Long-Term Investments	0.71	0.01	0.01	0.03	0.37
Other Intangible Assets	11.38	1.08	-	-	-
Long-Term Deferred Tax Assets	0.53	0.7	0.63	0.35	0.33
Other Long-Term Assets	3.15	26.17	0.93	0.82	0.86
Total Assets	159.18	127.95	51.18	39.59	36.43

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	3.35	6.02	2.77	5.08	3.83
Accrued Expenses	0.2	0.42	0.83	3.05	1.65
Short-Term Debt	27.85	5.19	5.9	8.86	8.64
Current Portion of Long-Term Debt	-	4.22	1.6	3.76	3.91
Current Income Taxes Payable	-	1.14	1.66	-	-
Other Current Liabilities	4.77	1.75	1.29	-0	-
Total Current Liabilities	36.17	18.74	14.05	20.74	18.03
Long-Term Debt	40.98	20.27	2.96	4.76	7.88
Pension & Post-Retirement Benefits	1.02	0.94	0.73	0.46	0.46
Other Long-Term Liabilities	0	-	-	-	-
Total Liabilities	78.17	39.94	17.74	25.96	26.37

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	87.12	43.56	19.6	15	15
Additional Paid-In Capital	-	39.46	10.5	-	-
Retained Earnings	-	4.99	3.34	-1.37	-4.94
Comprehensive Income & Other	-6.11	-	-	-	-
Shareholders' Equity	81.01	88.01	33.44	13.63	10.06
Total Liabilities & Equity	159.18	127.95	51.18	39.59	36.43

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	68.83	29.67	10.45	17.38	20.43
Net Cash (Debt)	-67.13	-28.72	-9.87	-16.89	-19.92
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-7.72	-3.30	-2.52	-3.16	-3.72
Filing Date Shares Outstanding	8.49	8.71	6.27	4.8	5.35
Total Common Shares Outstanding	8.49	8.71	6.27	4.8	5.35
Working Capital	16.8	23.67	10.32	-8.42	-4.71
Book Value Per Share	9.54	10.10	5.33	2.84	1.88
Tangible Book Value	69.63	86.93	33.44	13.63	10.06
Tangible Book Value Per Share	8.20	9.98	5.33	2.84	1.88
Land	-	3.86	3.69	3.69	3.69
Buildings	-	14.78	14.78	14.2	13.31
Machinery	-	31.86	28.68	25.65	20.19
Construction In Progress	-	32.76	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 27, 2026

Data Sources Report a data error